Objective To explore the predictive factors for hemodynamically significant patent ductus arteriosus (hsPDA) in preterm infants and to construct a nomogram prediction model for hsPDA occurrence in this population. Methods A retrospective analysis was conducted on the clinical data of preterm infants with gestational age <32 weeks diagnosed with patent ductus arteriosus (PDA) who were delivered at Nanjing Women and Children's Healthcare Hospital from January 2020 to December 2022. The subjects were divided into an hsPDA group (52 cases) and a non-hsPDA group (176 cases) based on the presence of hsPDA. Univariate analysis and multivariate logistic regression analysis were performed to screen predictive variables regarding the general information of the infants at birth, maternal pregnancy and delivery conditions, and relevant indicators during hospitalization. A nomogram prediction model for hsPDA occurrence was constructed using R software in preterm infants. Internal validation was performed using the Bootstrap method. Finally, the predictive model was evaluated for calibration, discrimination ability, and clinical utility. Results Multivariate regression analysis showed that the ratio of the left atrium to aorta diameter (LA/AO), mode of delivery (vaginal), and duration of mechanical ventilation were independent predictive factors for hsPDA in preterm infants (P<0.05). Based on the results of univariate analysis and multivariate logistic regression analysis, variables used to construct the nomogram prediction model for hsPDA risk included: LA/AO ratio, mode of delivery (vaginal), duration of mechanical ventilation, 5-minute Apgar score, and the presence of neonatal respiratory distress syndrome requiring surfactant therapy. The area under the receiver operating characteristic curve for this model was 0.876 (95%CI: 0.824-0.927), and the calibrated curve was close to the ideal reference line, indicating good calibration. The Hosmer-Lemeshow test demonstrated that the model fit well, and the clinical decision curve was above the extreme curves. Conclusions The nomogram prediction model, constructed using five variables (LA/AO ratio, vaginal delivery, duration of mechanical ventilation, 5-minute Apgar score, and the presence of neonatal respiratory distress syndrome requiring surfactant therapy), has reference significance for predicting the occurrence of hsPDA in preterm infants and provides valuable guidance for the early clinical identification of hsPDA.
Key words
Hemodynamically significant patent ductus arteriosus /
Predictive factor /
Nomogram model /
Preterm infant
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
References
1 Gao Y, Wu D, Chen B, et al. Rare variants in novel candidate genes associated with nonsyndromic patent ductus arteriosus identified with whole-exome sequencing[J]. Front Genet, 2022, 13: 921925. PMID: 35734438. PMCID: PMC9207465. DOI: 10.3389/fgene.2022.921925.
2 ElHassan NO, Bird TM, King AJ, et al. Variation and comparative effectiveness of patent ductus arteriosus pharmacotherapy in extremely low birth weight infants[J]. J Neonatal Perinatal Med, 2014, 7(3): 229-235. PMID: 25322995. DOI: 10.3233/NPM-14814015.
3 Mitra S, de Boode WP, Weisz DE, et al. Interventions for patent ductus arteriosus (PDA) in preterm infants: an overview of Cochrane systematic reviews[J]. Cochrane Database Syst Rev, 2023, 4(4): CD013588. PMID: 37039501. PMCID: PMC10091483. DOI: 10.1002/14651858.CD013588.pub2.
4 Deshpande P, Baczynski M, McNamara PJ, et al. Patent ductus arteriosus: the physiology of transition[J]. Semin Fetal Neonatal Med, 2018, 23(4): 225-231. PMID: 29779927. DOI: 10.1016/j.siny.2018.05.001.
5 Clyman RI. Patent ductus arteriosus in the preterm infant[M]//Gleason CA, Devaskar SU. Avery's Diseases of the Newborn. 9th ed. Philadelphia: W.B. Saunders, 2012: 751-761.
6 邵肖梅, 叶鸿瑁, 丘小汕. 实用新生儿学[M]. 4版. 北京: 人民卫生出版社, 2011.
7 Conrad C, Newberry D. Understanding the pathophysiology, implications, and treatment options of patent ductus arteriosus in the neonatal population[J]. Adv Neonatal Care, 2019, 19(3): 179-187. PMID: 30720481. DOI: 10.1097/ANC.0000000000000590.
8 H?rkin P, Marttila R, Pokka T, et al. Morbidities associated with patent ductus arteriosus in preterm infants. Nationwide cohort study[J]. J Matern Fetal Neonatal Med, 2018, 31(19): 2576-2583. PMID: 28651469. DOI: 10.1080/14767058.2017.1347921.
9 Shepherd JL, Noori S. What is a hemodynamically significant PDA in preterm infants?[J]. Congenit Heart Dis, 2019, 14(1): 21-26. PMID: 30548469. DOI: 10.1111/chd.12727.
10 Jain A, Shah PS. Diagnosis, evaluation, and management of patent ductus arteriosus in preterm neonates[J]. JAMA Pediatr, 2015, 169(9): 863-872. PMID: 26168357. DOI: 10.1001/jamapediatrics.2015.0987.
11 de Boode WP, Kluckow M, McNamara PJ, et al. Role of neonatologist-performed echocardiography in the assessment and management of patent ductus arteriosus physiology in the newborn[J]. Semin Fetal Neonatal Med, 2018, 23(4): 292-297. PMID: 29551482. DOI: 10.1016/j.siny.2018.03.007.
12 Rios DR, Martins FF, El-Khuffash A, et al. Early role of the atrial-level communication in premature infants with patent ductus arteriosus[J]. J Am Soc Echocardiogr, 2021, 34(4): 423-432.e1. PMID: 33227390. PMCID: PMC8026594. DOI: 10.1016/j.echo.2020.11.008.
13 刘太祥, 马晓路, 陈军津, 等. 生后早期床旁心脏超声预测极低出生体重儿动脉导管持续开放的研究[J]. 中国当代儿科杂志, 2022, 24(1): 26-32. PMID: 35177172. PMCID: PMC8802380. DOI: 10.7499/j.issn.1008-8830.2109087.
14 Hsu KH, Nguyen J, Dekom S, et al. Effects of patent ductus arteriosus on organ blood flow in infants born very preterm: a prospective study with serial echocardiography[J]. J Pediatr, 2020, 216: 95-100.e2. PMID: 31610928. DOI: 10.1016/j.jpeds.2019.08.057.
15 Engür D, Deveci M, Türkmen MK. Early signs that predict later haemodynamically significant patent ductus arteriosus[J]. Cardiol Young, 2016, 26(3): 439-445. PMID: 25826049. DOI: 10.1017/S1047951115000372.
16 van Laere D, van Overmeire B, Gupta S, et al. Application of NPE in the assessment of a patent ductus arteriosus[J]. Pediatr Res, 2018, 84(Suppl 1): 46-56. PMID: 30072803. PMCID: PMC6257219. DOI: 10.1038/s41390-018-0077-x.
17 Willis KA, Weems MF. Hemodynamically significant patent ductus arteriosus and the development of bronchopulmonary dysplasia[J]. Congenit Heart Dis, 2019, 14(1): 27-32. PMID: 30343505. DOI: 10.1111/chd.12691.
18 Hamrick SEG, Sallmon H, Rose AT, et al. Patent ductus arteriosus of the preterm infant[J]. Pediatrics, 2020, 146(5): e20201209. PMID: 33093140. PMCID: PMC7605084. DOI: 10.1542/peds.2020-1209.
19 Chen YY, Wang HP, Chang JT, et al. Perinatal factors in patent ductus arteriosus in very low-birthweight infants[J]. Pediatr Int, 2014, 56(1): 72-76. PMID: 23937654. DOI: 10.1111/ped.12199.
20 Ognean ML, Boant? O, Kovacs S, et al. Persistent ductus arteriosus in critically ill preterm infants[J]. J Crit Care Med (Targu Mures), 2016, 2(4): 175-184. PMID: 29967857. PMCID: PMC5953255. DOI: 10.1515/jccm-2016-0026.
21 Kim ES, Kim EK, Choi CW, et al. Intrauterine inflammation as a risk factor for persistent ductus arteriosus patency after cyclooxygenase inhibition in extremely low birth weight infants[J]. J Pediatr, 2010, 157(5): 745-750.e1. PMID: 20598319. DOI: 10.1016/j.jpeds.2010.05.020.
22 Meinarde L, Hillman M, Rizzotti A, et al. C-reactive protein, platelets, and patent ductus arteriosus[J]. Platelets, 2016, 27(8): 821-823. PMID: 27463781. DOI: 10.1080/09537104.2016.1203398.
23 Canpolat FE, Kad?o?lu ?im?ek G, Webbe J, et al. Late administration of surfactant may increase the risk of patent ductus arteriosus[J]. Front Pediatr, 2020, 8: 130. PMID: 32296667. PMCID: PMC7138194. DOI: 10.3389/fped.2020.00130.
PDF(759 KB)
